2026 ICD-10-CM Diagnosis Code T53.93XSToxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault, sequela
T53.93XS is a billable ICD-10-CM diagnosis code for toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.
Code Identity
Code Classification
Present on Admission (POA)Billing
T53.93XS is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Coding GuidelinesGuidance
The appropriate 7th character is to be added to each code from block Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons (T53). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Convert T53.93XS to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About T53.93XSOverview
Is T53.93XS a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character S in T53.93XS mean?
The final character S makes this a sequela code: it reports a lingering problem that remains after the toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault itself has resolved, not the original event.
What MS-DRG does T53.93XS group to?
When toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.
Is T53.93XS exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault, sequela on inpatient claims.
What is the ICD-9 equivalent of T53.93XS?
Under the General Equivalence Mappings, toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault, sequela converts to ICD-9-CM 909.1 (late eff nonmed substanc). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
